SE396601B - Forfarande for framstellning av arylalkyl-pyrrylaminoetanoler - Google Patents

Forfarande for framstellning av arylalkyl-pyrrylaminoetanoler

Info

Publication number
SE396601B
SE396601B SE7213898A SE1389872A SE396601B SE 396601 B SE396601 B SE 396601B SE 7213898 A SE7213898 A SE 7213898A SE 1389872 A SE1389872 A SE 1389872A SE 396601 B SE396601 B SE 396601B
Authority
SE
Sweden
Prior art keywords
pyrrylaminoetanols
arylalkyl
procedure
preparation
Prior art date
Application number
SE7213898A
Other languages
English (en)
Swedish (sv)
Inventor
Bella D Della
C Veneziani
D Chiarino
Original Assignee
Whitefin Holding Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitefin Holding Sa filed Critical Whitefin Holding Sa
Publication of SE396601B publication Critical patent/SE396601B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7213898A 1971-10-30 1972-10-27 Forfarande for framstellning av arylalkyl-pyrrylaminoetanoler SE396601B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT3058671 1971-10-30
IT3058571 1971-10-30

Publications (1)

Publication Number Publication Date
SE396601B true SE396601B (sv) 1977-09-26

Family

ID=26328881

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7213898A SE396601B (sv) 1971-10-30 1972-10-27 Forfarande for framstellning av arylalkyl-pyrrylaminoetanoler

Country Status (12)

Country Link
JP (1) JPS5530514B2 (cs)
CA (1) CA996941A (cs)
CH (1) CH572909A5 (cs)
CS (1) CS179403B2 (cs)
DK (1) DK133670B (cs)
ES (1) ES408077A1 (cs)
FI (1) FI54705C (cs)
HU (1) HU164701B (cs)
NL (1) NL7214581A (cs)
RO (1) RO62754A (cs)
SE (1) SE396601B (cs)
SU (1) SU453834A3 (cs)

Also Published As

Publication number Publication date
CA996941A (en) 1976-09-14
JPS5530514B2 (cs) 1980-08-11
DK133670B (da) 1976-06-28
NL7214581A (cs) 1973-05-02
JPS4852765A (cs) 1973-07-24
FI54705B (fi) 1978-10-31
DK133670C (cs) 1976-11-15
CH572909A5 (en) 1976-02-27
CS179403B2 (en) 1977-10-31
HU164701B (cs) 1974-03-28
ES408077A1 (es) 1976-02-01
FI54705C (fi) 1979-02-12
SU453834A3 (ru) 1974-12-15
RO62754A (ro) 1982-09-09

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
SE390633B (sv) Forfarande for framstellning av ethambutol
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE393615B (sv) Forfarande for framstellning av 6-metyl-8 beta-ureidometyl-ergolener
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE412756B (sv) Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE380815B (sv) Forfarande for framstellning av transparenta sampolyamider
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE382985B (sv) Forfarande for framstellning av oxazoler
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE398123B (sv) Forfarande for framstellning av metoximetylestern av hetacillin
SE387948B (sv) Forfarande for framstellning av tiofen
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner